Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Schedule of stock option activity (Details)

v3.24.1.u1
Stockholders' Equity - Schedule of stock option activity (Details) - USD ($)
12 Months Ended
Feb. 04, 2024
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Number of options        
Number of options, outstanding, beginning balance (in shares) 495,366 495,366 495,366  
Number of options, Issued (in shares) 0 0 0  
Number of options, Canceled and forfeited (in shares) 0 0 0  
Number of options, Exercised (in shares) 0 0 0  
Number of options, outstanding, ending balance (in shares) 495,366 495,366 495,366 495,366
Number of options, exercisable at the end of the period (in shares) 495,366      
Weighted average exercise price        
Weighted average exercise price, outstanding balance (in dollars per share) $ 38.10 $ 38.10 $ 38.10  
Weighted average exercise price, issued (in dollars per share) 0 0 0  
Weighted average exercise price, canceled and forfeited (in dollars per share) 0 0 0  
Weighted average exercise price, exercised (in dollars per share) 0 0 0  
Weighted average exercise price, outstanding balance (in dollars per share) 38.10 $ 38.10 $ 38.10 $ 38.10
Weighted average exercise price, exercisable at the end of the period (in dollars per share) $ 38.10      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]        
Weighted average remaining contractual life, outstanding (in years) 5 years 4 months 2 days 1 year 4 months 6 days 2 years 4 months 6 days 3 years 4 months 6 days
Average intrinsic value, Outstanding $ 0 $ 0 $ 6,162,000 $ 9,135,000
Average intrinsic value, exercisable $ 0